PEDIATRICS Vol. 40 No. 2 August 1967, pp. 309
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Letters to the Editor

The letter by Dr. Chase and Dr. O'Brien is welcome and interesting.

One intention of our report was to stem that trend toward treatment of all premature and full-term infants as if they had tyrosinemia, which we thought might be construed from the current interest in this condition. It was not our purpose to quell interest in finding and managing the individual infant with tyrosinemia. In fact, we emphasized "the need to ascertain the individual significance of neonatal tyrosinemia;" this includes detection and management.